Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes

Int J Cardiol. 2008 Mar 14;124(3):366-7; author reply 368-9. doi: 10.1016/j.ijcard.2007.01.061. Epub 2007 Apr 2.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Anti-Arrhythmia Agents / administration & dosage
  • Anti-Arrhythmia Agents / adverse effects*
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Heart Rate / drug effects
  • Humans
  • Incidence
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / epidemiology
  • Male
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Sex Factors
  • Sotalol / administration & dosage
  • Sotalol / adverse effects*
  • Torsades de Pointes / chemically induced*
  • Torsades de Pointes / epidemiology

Substances

  • Anti-Arrhythmia Agents
  • Sotalol